Skip to main content
Premium Trial:

Request an Annual Quote

Lexicon to Use BioSeek Tools for Drug Discovery

NEW YORK (GenomeWeb News) – BioSeek said today that Lexicon Pharmaceuticals will use the firm’s BioMAP systems to evaluate selected compounds associated with Lexicon’s drug discovery programs.
The BioMAP systems use predictive primary human cell-based disease models that generate profiles for drug candidates.
“By providing predictive preclinical human data on the pharmacological properties of Lexicon's compounds, the BioMAP platform can help to discern the relevant physiologic pathway impacted by the compounds and identify appropriate cellular assays for their further optimization,” Michael venuti, CEO of BioSeek, said in a statement.
Terms of the deal were not disclosed.

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.